Khosrow Kashfi Selected Research

NF-kappa B (NF-kB)

4/2006	Nitric oxide-donating aspirin prevents pancreatic cancer in a hamster tumor model.
7/2004	Nitric-oxide-donating NSAIDs as agents for cancer prevention.
11/2003	Growth inhibition of human colon cancer cells by nitric oxide (NO)-donating aspirin is associated with cyclooxygenase-2 induction and beta-catenin/T-cell factor signaling, nuclear factor-kappaB, and NO synthase 2 inhibition: implications for chemoprevention.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Khosrow Kashfi Research Topics

Disease

48	Neoplasms (Cancer) 06/2023 - 12/2002
22	Colonic Neoplasms (Colon Cancer) 12/2015 - 02/2002
18	Type 2 Diabetes Mellitus (MODY) 01/2024 - 01/2019
11	Inflammation (Inflammations) 01/2023 - 11/2010
10	Carcinogenesis 01/2023 - 10/2003
6	Infarction (Infarctions) 01/2024 - 02/2020
5	Myocardial Ischemia (Ischemic Heart Diseases) 01/2024 - 02/2020
5	Reperfusion Injury 01/2024 - 02/2020
5	Insulin Resistance 11/2023 - 11/2017
5	Body Weight (Weight, Body) 10/2022 - 10/2018
4	Obesity 01/2024 - 10/2018
4	Breast Neoplasms (Breast Cancer) 01/2023 - 11/2009
4	Hyperalgesia 12/2015 - 11/2010
4	Leukemia 03/2012 - 01/2005
3	Ischemia 01/2024 - 01/2022
3	Hyperglycemia 11/2023 - 01/2019
3	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2022
3	Osteoporosis 01/2022 - 01/2020
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020 - 12/2002
3	Stomach Ulcer (Gastric Ulcer) 12/2015 - 04/2013
3	Edema (Dropsy) 01/2015 - 03/2012
2	Myocardial Infarction 01/2024 - 05/2022
2	Hypercholesterolemia 06/2023 - 05/2022
2	Dyslipidemias (Dyslipidemia) 01/2023 - 01/2022
2	Alzheimer Disease (Alzheimer's Disease) 09/2022 - 10/2021
2	Glucose Intolerance 03/2022 - 01/2022
2	Brucellosis (Malta Fever) 03/2022 - 12/2018
2	Hypoxia (Hypoxemia) 01/2022 - 01/2019
2	Wounds and Injuries (Trauma) 03/2021 - 10/2020
2	Triple Negative Breast Neoplasms 01/2021 - 03/2012
2	Hemorrhage 12/2015 - 12/2015
2	Adenocarcinoma 03/2012 - 04/2006
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2010 - 06/2010
2	Lung Neoplasms (Lung Cancer) 01/2009 - 12/2002
2	Carcinoma (Carcinomatosis) 04/2006 - 10/2003
1	Residual Neoplasm 03/2023

Drug/Important Bio-Agent (IBA)

40	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2024 - 12/2002
22	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2023 - 03/2012
22	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 10/2003
15	nitroxy-butyl-acetylsalicylic acidIBA 07/2015 - 10/2003
13	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2022 - 02/2002
11	NitratesIBA 01/2024 - 10/2018
10	EnzymesIBA 01/2023 - 10/2005
9	4-(3-thioxo-3H-1,2-dithiol-5-yl)phenyl 2-((4-(nitrooxy)butanoyl)oxy)benzoateIBA 01/2020 - 03/2012
6	NitritesIBA 01/2024 - 10/2020
6	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2022 - 11/2003
6	CarrageenanIBA 12/2015 - 11/2010
5	Proteins (Proteins, Gene)FDA Link 03/2023 - 06/2010
5	Dinoprostone (PGE2)FDA Link 01/2022 - 07/2005
5	Nitric Oxide Synthase (NO Synthase)IBA 01/2022 - 11/2003
5	Sulindac (Copal)FDA LinkGeneric 12/2015 - 12/2002
5	nitroaspirinIBA 07/2015 - 01/2004
5	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 04/2006 - 11/2003
4	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 01/2022
4	Insulin (Novolin)FDA Link 09/2022 - 11/2017
4	CytokinesIBA 01/2022 - 06/2015
4	Messenger RNA (mRNA)IBA 01/2022 - 01/2019
4	Analgesics (Analgesic Drugs)IBA 01/2016 - 11/2010
4	Naproxen (Naprosyn)FDA LinkGeneric 01/2015 - 12/2010
4	4-(5-thioxo-5H-1,2-dithiol-3-yl)-phenyl 2-acetoxybenzoateIBA 10/2013 - 03/2012
4	CarcinogensIBA 03/2012 - 04/2006
4	beta CateninIBA 06/2010 - 10/2003
3	Streptozocin (Streptozotocin)FDA Link 01/2024 - 01/2019
3	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2023 - 07/2015
3	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2022 - 07/2005
3	AntipyreticsIBA 01/2016 - 11/2010
3	TCF Transcription FactorsIBA 01/2013 - 10/2003
3	NF-kappa B (NF-kB)IBA 04/2006 - 11/2003
3	N- acetyl- S- (alpha- methyl- 4- (2- methylpropyl)benzeneacetyl)cysteine 4-(nitrooxy)butyl esterIBA 07/2004 - 12/2002
2	LipidsIBA 01/2024 - 11/2021
2	serum P-component (CIt)IBA 01/2024 - 01/2023
2	CitrullineIBA 01/2024 - 01/2023
2	chemotactic factor inactivatorIBA 01/2024 - 01/2023
2	CholesterolIBA 06/2023 - 01/2022
2	Transcription Factors (Transcription Factor)IBA 01/2023 - 02/2014
2	Carbon MonoxideIBA 01/2023 - 01/2022
2	VaccinesIBA 11/2022 - 03/2022
2	Attenuated VaccinesIBA 03/2022 - 12/2018
2	sodium bisulfide (NaHS)IBA 09/2020 - 02/2020
2	Drinking WaterIBA 01/2020 - 01/2019
2	Caspase 3 (Caspase-3)IBA 01/2020 - 01/2013
2	Estrogen ReceptorsIBA 07/2015 - 03/2012
2	CateninsIBA 01/2013 - 12/2010
2	Flurbiprofen (Froben)FDA LinkGeneric 01/2013 - 06/2004
2	Cyclin D1IBA 01/2013 - 10/2003
2	XenobioticsIBA 03/2012 - 01/2009
2	ProdrugsIBA 12/2010 - 11/2010
2	EicosanoidsIBA 10/2005 - 07/2005
2	Indomethacin (Indometacin)FDA LinkGeneric 06/2004 - 12/2002
2	Ibuprofen (Motrin)FDA LinkGeneric 06/2004 - 12/2002
1	Pyruvic Acid (Pyruvate)IBA 01/2024
1	Vasodilator Agents (Vasodilators)IBA 11/2023
1	PCSK9 InhibitorsIBA 06/2023
1	MelatoninIBA 01/2023
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2023

Therapy/Procedure

12	Therapeutics 10/2023 - 01/2009
6	Chemoprevention 01/2009 - 02/2002
2	Ovariectomy (Oophorectomy) 01/2022 - 01/2020
1	Radiotherapy 03/2023
1	Immunotherapy 03/2023